The aim of this work was to use several new biological indicators to evaluate damage to the main physiological systems in a victim exposed accidentally to ionizing radiation. Blood samples were used for biological dosimetry and for measurement of the plasma concentrations of several molecules: Flt3 ligand to assess the hematopoietic system, citrulline as an indicator of the digestive tract, and several oxysterols as lipid metabolism and vascular markers. The cytogenetic evaluation estimated the dose to the victim to be between 4.2 and 4.8 Gy, depending on the methodology used. Monitoring the Flt3 ligand demonstrated the severity of bone marrow aplasia. In contrast, the citrulline concentration showed the absence of gastrointestinal damage. Variations in oxysterol concentrations suggested radiation-induced damage to the liver and the cardiovascular system. These results were correlated with those from classic biochemical markers, which demonstrated severe damage to the hematopoietic system and suggested the appearance of subclinical damage to the liver and cardiovascular system. These results demonstrate for the first time the importance of a multiparameter biological approach in the evaluation of radiation damage after accidental irradiation.
INTRODUCTION
Radiation accidents are rare events that induce a complex and difficult-to-treat pathology, the acute radiation syndrome (1, 2) . The reasons for this difficulty include uncertainty about the accident's circumstances and about the dose, dose rate and heterogeneity of the dose received (3) . Moreover, because of the nonspecificity of the symptoms, radiation accidents often are not recognized as such for sev-eral days or weeks (4) . Thus medical teams that must manage victims of these radiation accidents must evaluate not only the global radiation dose received, by biological dosimetry (5) , but also the radiation-induced damage, especially any life-threatening damage, to different physiological systems.
This physiological evaluation is usually made by standard laboratory tests, combined with some tests that are more or less specific for radiation. Two specific bioindicators of radiation damage have been described: serum amylase concentration (6, 7) , an indicator of radiation damage to the parotid glands, and the decrease in lymphocyte counts during the first 48 h postirradiation, which was used, for example, to evaluate the global severity of radiation damage after the Chernobyl accident (8) . These biological indicators are not available in all cases, however, mainly because of delays in recognizing the radiological origin of the patients' symptoms. To improve the evaluation of radiation damage and victim triage, multiparameter approaches have been developed that are based on a variety of indicators for hematopoietic, gastrointestinal, neurological and cutaneous organ systems. This method, named ME-TREPOL (2, 9) , gives a specific score describing the extent of the damage to the most critical organ systems, i.e., the neurovascular system, the hematopoietic system, the skin and the gut. This results in a grading score (i.e. mild, moderate, severe and serious/fatal damage) that may be associated with a response category (2, 9) . The METREPOL score was developed to help define a therapeutic strategy adapted to each case. Nevertheless, this approach uses only the complete blood count to evaluate the hematopoietic syndrome and does not evaluate other organs such as the liver, kidneys or cardiovascular system.
There is accordingly a crucial need to combine new biological indicators that can provide information about the severity of radiation-induced damage to specific physiological systems. Recent reports describe two such biological indicators: the plasma concentrations of Flt3 ligand (FL) (10, 11) and citrulline (12, 13) . The FL concentration correlates with the extent of bone marrow aplasia after irra-diation (10, 11) , after chemotherapy (14) , and during aplastic anemia (15) . Thus it may be useful for the evaluation of damage to the hematopoietic system after accidental irradiation. Citrulline is an amino acid specifically produced by enterocytes (12) , and its concentration is correlated with the enterocyte mass in some pathological situations such as small bowel disease (12) and after irradiation (13) . Its follow-up might thus serve as a biological indicator of gastrointestinal damage. Interestingly, the variations in the concentrations of these two markers in previous studies appeared to be independent of the damaging agent but were highly specific to the physiological system tested. Moreover, recent data indicate that oxysterol concentrations may be useful in evaluating hepatic, pulmonary, cardiovascular and central nervous system functions, since changes in the levels of these products of cholesterol metabolism are associated with specific disorders (16, 17) . None of these biological indicators, however, had previously been used after a radiation accident.
We describe here for the first time the use of several of these indicators to monitor a radiation accident victim. Our results show that they may be useful not only for the initial evaluation of radiation damage but also for monitoring the patient's pathophysiological course.
PATIENT AND METHODS

Case Presentation
On March 11, 2006, a technician turned off an alarm and entered an irradiation room without noticing that the cobalt-60 sources (total activity 3 ϫ 10 4 TBq) were partly out of the security position. They irradiated the room when he entered. At that time, the general health status of this 50-year-old Caucasian male was good. A few hours after he exited the irradiation device, the victim had nausea and vomiting, but these signs were not linked to possible ionizing radiation exposure. Eighteen days later, he consulted for persistent nausea, transitory but refractory diarrhea, persistent headache and hair loss. At that time, a possible radiation accident was considered as a explanation for these symptoms. The circumstances of the accident were reconstructed to evaluate the global radiation dose received (18) , calculated at 4.5 Gy with a gradient from back to front and bottom-up. On day 20 (March 31, 2006) , the patient was admitted to the Percy Hospital (Clamart, France) hematology department for pancytopenia. Platelet injections began the next day and cytokine injections [a combination of pegylated granulocyte-colony stimulating factor (pegG-CSF), stem cell factor (SCF) and erythropoietin (EPO)] a week later (day 28), as described elsewhere (19) . During hospitalization, blood parameters were monitored, with his informed consent in accordance with current French regulations. Some of the parameters monitored are described elsewhere [(19) and T. De Revel and T. Fagot, in preparation].
Cytogenetic Dosimetry
Blood was drawn into heparinized tubes (Vacutainer, BD Biosciences, Le Pont de Claix, France) and then treated as described elsewhere (5, 20) . Briefly, total blood was diluted 1:10 in RPMI 1640 medium supplemented with penicillin/streptomycin, glutamine, fetal calf serum (FCS) (all from BD Biosciences), and 1% PHA-M. After 46 h of culture at 37ЊC in 95% air/5% CO 2 , colchicine (BD Biosciences) was added to block proliferative cells during their first division, and cultures were stopped at 48 h. After a KCl shock (0.075 M, Sigma-Aldrich, Saint Quentin Fallavier, France), cells were spread onto glass slides, fixed and stained with Hoechst and Giemsa stains, as described elsewhere (20) . Metaphases were then scored, together with chromosome aberrations. Fluorescence in situ hybridization (FISH) was also performed on some slides to detect translocations, as described previously (21) . Three chromosome pairs were labeled and both total and reciprocal translocations were scored. The radiation dose received by the patient was then calculated according to a reference curve established in the laboratory from blood samples irradiated in vitro with a cobalt-60 source at a dose rate of 0.5 Gy/min (22) .
Blood Follow-up
Blood samples were drawn daily into EDTA-coated tubes (Vacutainer, BD Biosciences) for a complete blood cell count, including reticulocytes, in an ADVIA 120 hematology counter (Bayer, Cergy Pontoise, France). Plasma was isolated by centrifugation for 10 min at 800g and frozen for later use. White blood cells (WBC) were then isolated by ammonium chloride lysis and washed twice in phosphate-buffered saline (PBS) solution supplemented with 0.5% bovine serum albumin (BSA, Sigma-Aldrich). WBC were then counted, and their viability was assessed by trypan blue dye exclusion.
Phenotypic Analysis of WBC
The following directly labeled antibodies were used: IgG1-FITC, -PE and Cy5 (clone 679.1Mc7), anti-CD2-Cy5 (clone 39C1.5), anti-CD8-FITC (clone B9.11), anti-CD11b-FITC and -PE (clone Bear1), anti-CD14-PC5 (clone RMO52), anti-CD16-FITC (clone3G8) (all from Beckman-Coulter, Marseille, France), anti-CD4-PE (clone SK3), anti-CD20-PerCP (clone L27), anti-CD34-PE (clone 581) and anti-CD56-PE (clone B159) (all from BD Biosciences). WBC (1 ϫ 10 5 ) were resuspended in 100 l PBS 0.5% BSA, and the antibodies indicated were added at predefined concentrations. After incubation for 20 min at 4ЊC, cells were washed twice in PBS 0.5% BSA. 7-Amino-actinomycin D was added at a final concentration of 1 g/ml to exclude dead cells from analysis. Cells were then analyzed onto a FACSCalibur (BD Biosciences), with the acquisition of at least 10,000 events per point.
Colony-Forming Assay
WBC were resuspended in MEM alpha at a cell concentration of 2 ϫ 10 6 cells/ml, and 300 l was mixed with a 3-ml methylcellulose medium (Stem Cell Technologies, France) supplemented with the following recombinant human cytokines: 20 ng/ml interleukin 3 (IL3), 50 ng/ml granulocyte-colony stimulating factor (G-CSF), 5 ng/ml granulocyte-macrophage CSF (GM-CSF), 50 ng/ml stem cell factor (SCF) and 3 U/ml erythropoietin (EPO). Cultures were then incubated at 37ЊC and 95% air/5% CO 2 , and colony-forming units-granulocyte-macrophage (CFU-GM) and burst-forming units-erythroid (BFU-E) were scored on day 12 of culture.
Flt3 Ligand (FL) Measurement
FL was measured with a commercially available ELISA system (R&D Systems, Abingdon, UK), according to the manufacturer's recommendations. The sensitivity of the test was less than 7 pg/ml of plasma.
Citrulline Measurement
Twice a week, a blood sample was taken into heparinized tubes. Plasma was isolated by centrifugation at 800g for 10 min and frozen. Citrulline was measured by chromatographic methods, as described elsewhere (13) .
Analysis of Oxysterols and Biochemical Assays
Plasma samples of creatinine, urea, alanine aminotransferase (ALT), aspartate transferase (AST), total cholesterol, high-density lipoproteins (HDL), low-density lipoproteins (LDL), apolipoproteins (ApoA1 and Note. Radiation doses were calculated according to a reference curve for cobalt-60 (20) . a 42 cells had more than 1 aberration and 51 cells had no chromosomal aberration.
ApoB), triglycerides and creatine kinases (CK and CK-MB) were assayed in a Konelab 20 biochemical automatic device (Thermo Fisher Scientific, Illkirch, France) with specific kits (all from Thermo Fisher Scientific) and according to the manufacturer's recommendations. Oxysterols were analyzed as described elsewhere (23) . Briefly, after alkaline hydrolysis of a 1-ml EDTA plasma sample, oxysterols were extracted by hexane and then treated with cholesterol oxydase. High-performance liquid chromatography of the samples at 240 nm were compared with plasma samples containing known quantities of each oxysterol analyzed, that is, 24S-hydroxycholesterol (24S-OH-Chol), 27-hydroxycholesterol (27-OH-Chol) and 7␣-hydroxycholesterol (7␣-OH-Chol).
RESULTS
Biological Dosimetry
At admission, the patient (a 50-year-old Caucasian man) had pancytopenia, associated with partial alopecia, persistent nausea and headache. None of these signs, however, are specific for radiation exposure since each can be associated with other diseases, such as idiopathic aplasia. The observation of a large number of chromosome aberrations and particularly dicentric chromosomes in the lymphocytes thus confirmed that the patient was accidentally irradiated.
The precise scoring of the different types of chromosome aberrations then made it possible to estimate the radiation dose received (20) . Table 1 gives the frequencies of dicentric chromosomes, reciprocal translocations and total translocations, as well as the estimated dose associated with each type of aberration. Overall, the correlation between the doses calculated from these different scores was good. This finding confirms that either dicentrics or translocations can feasibly be used for biological dosimetry when the delay between irradiation and chromosomal analysis is less than a few weeks (24) . These results estimated a mean radiation dose of 4.5 Gy and thus confirmed the results from the physical reconstruction of the accident (18) .
The statistical analysis of the distributions of dicentrics and rings showed a Poisson distribution without overdispersion (U-test value of 1.8). However, since 18.8% of cells (26/139 cells scored) had no aberrations, data were analyzed with a specific mathematical model (QDR model) (25) that assumed heterogeneous exposure. This analysis showed that the dose delivered to the exposed portion of blood was slightly higher than the dose determined on the assumption of homogeneous exposure. Such contradictory results are obtained when exposure is slightly heterogeneous (L. Roy, personal communication). The anterior-posterior gradient of the dose measured by physical dosimetry also suggested a heterogeneous dose distribution (18) and provided an explanation for the 18.8% of the cells that were free of aberrations. Overall, this analysis suggested a heterogeneous radiation exposure. This information is of crucial importance in the prognosis for both the hematopoietic syndrome and the acute radiation syndrome.
Follow-up of Blood Counts
As indicated, the patient had severe pancytopenia at admission. This was confirmed by monitoring the complete blood count, which showed a decrease in all cell types, including platelets (Fig. 1) . Platelet transfusions were started to treat the severe thrombocytopenia by day 21 postirradiation and cytokine injections for the pancytopenia on day 28 (19) . This resulted in an increase in the number of WBC until complete recovery on day 33. Interestingly, on day 19, the lymphocyte count per liter was 0.6 ϫ 10 9 , with these cells accounting for 50% of circulating WBC. Since the disappearance of lymphocytes takes place mainly during the first 48 h postirradiation and is dependent on dose (8), a high proportion of lymphocytes clearly survived irradiation. This strongly suggested heterogeneous exposure.
Radiation Damage to the Hematopoietic System
The evaluation of residual hematopoiesis is crucial for the treatment of radiation accident victims. We used four different methods for that purpose: enumeration of reticulocytes, CD34
ϩ peripheral blood progenitors (PBP), and clonogenic circulating progenitors as well as FL concentration measurement. At admission, the FL concentration ( Fig.  2A ) was 35 times higher than the normal levels defined in a healthy population (112 Ϯ 24 pg/ml plasma) (10), thus indicating severe radiation damage to the hematopoietic system (14) . It decreased immediately afterward, however, and stayed in the range of 2500-3700 pg/ml until cytokine treatment began. These findings suggest that the hematopoietic syndrome was at its nadir. As soon as cytokine treatment started, the FL concentration decreased rapidly and continuously, indicating recovery of hematopoietic activity. Aplasia was reversed on day 33, and a normal FL concentration was reached on day 35 .
Circulating CD34 ϩ PBP were 40-fold lower than in a control population (6.08 ϫ 10 5 CD34 ϩ PBP/liter blood compared with 25.1 ϫ 10 6 Ϯ 13.5 ϫ 10 6 CD34 ϩ PBP/liter) (Fig. 2B) . This suggested the presence of residual hematopoiesis, despite the severe bone marrow damage indicated by the high plasma FL concentration. The number of circulating CD34 ϩ PBP remained constant until the beginning of cytokine treatment. Thereafter, the circulating CD34 ϩ PBP count returned to normal values.
Experimental models show that clonogenic circulating progenitors are correlated with marrow function after irradiation (26) . The number of BFU-E was 100-fold lower than normal levels from a panel of six healthy donors, and CFU-GM were barely detectable during the first week of follow-up (Fig. 2C) . Nonetheless, the presence of any BFU-E during this period and the slight increase in clonogenic progenitor frequencies before the cytokine treatment did indicate active hematopoiesis. These results also suggested that circulating CD34
ϩ PBP were at least partially functional. Thereafter, the number of clonogenic progenitors increased up to 100-fold higher than normal levels for more than 2 weeks. This prolonged high frequency of both BFU-E and CFU-GM was probably due to the sustained effect of the pegylated form of G-CSF used to treat the radiation-induced bone marrow aplasia (19) .
Reticulocytes were below 0.4% for the first 5 days of follow-up (Fig. 2D ) but increased very slightly between day 25 and day 28 postirradiation, suggesting some hematopoietic activity during the WBC nadir. Thereafter, and during the initial part of cytokine treatment, the percentage of reticulocytes varied substantially, until the recovery period when it increased rapidly and consistently.
Radiation Damage to the Gastrointestinal Tract
The patient experienced nausea and vomiting within hours of irradiation but did not show any of the classic signs of the gastrointestinal syndrome, which can include massive hemorrhagic diarrhea, with dehydration and electrolyte loss. The dose reconstruction with numerical methods, however, indicated that the abdominal region had received a radiation dose close to that which induces gastrointestinal syndrome. Mucosal denudation of the intestine was then evaluated by the plasma citrulline concentration, as described previously (12, 13) . At 24-36 mol/liter plasma (Fig. 3) , it was within the normal range for men aged 40-60 years (34 Ϯ 8 mol/liter of plasma) (13) . This demonstrated the absence of significant mucosal damage in the small bowel.
Radiation Damage to the Metabolism
Two oxysterols were monitored in the plasma: 24S-OHChol, which is produced by the central nervous system (27) , and 7␣-OH-Chol, which is specifically associated with the liver (28) . The normal range of 24S-OH-Chol is 15 Ϯ 5 M (29), but it was undetectable in the patient's plasma (data not shown). The decrease in 7␣-OH-Chol over time after irradiation suggested possible radiation damage to the liver (Fig. 4A) , since the normal range is 0.6 Ϯ 0.1 M (data not shown). Creatinine and blood urea were at normal levels (data not shown) during the same period, which indicated that there was no detectable kidney damage at that time. AST and ALT decreased, however (Fig. 4B) , and the lipid balance was modified (Fig. 4C and D) . Apolipoprotein A1 (Apo A1) began to decrease on day 23 postirradiation, total cholesterol on day 27, and high-density lipoproteins (HDL) on day 31. Overall, these results suggest that radiation induced functional liver impairment, which in response caused some changes in hepatic lipid metabolism.
Radiation Damage to the Cardiovascular System
27-OH-Chol is produced mainly by the lungs and the cardiovascular system. 27-OH-Chol levels varied greatly during follow-up, from 1 to 60 M; the normal range is 45 Ϯ 15 M (30) (Fig. 5A) . A confirmation of this apparent disruption in the cardiovascular system was obtained by measuring CK and CK-MB. The results (Fig. 5B) indicated that CK was below 200 U/liter, i.e., within the range of normal values, but CK-MB, present in the myocardial tissue, increased above the normal range between days 35 and 40. These results suggest radiation-induced damage to the cardiovascular system, despite the absence of any clinical signs of a cardiac disorder, such as electrocardiogram alterations (19) .
DISCUSSION
The last two reported examples of large-field, high-dose accidental irradiation are the accidents in Tokai-Mura (Japan, 1999) (31) and Nesvizh (Byelorussia, 1991) (32) . Both led to an acute radiation syndrome, with the involvement or the failure of multiple organs and physiological systems. Here the radiation dose and distribution (18) produced a pure hematopoietic syndrome, without any clinical manifestations of gastrointestinal, neurological or cutaneous syndromes. Indeed, at admission (on day 19), the patient had severe pancytopenia, without any other clinical signs (19) . A careful history, however, revealed that the patient had experienced nausea and vomiting the afternoon of the accident. These symptoms were mistaken for benign gastroenteritis. Such confusion between the initial syndrome and other diseases is very frequent (4) and in this case caused the patient's late presentation and treatment.
In such radiation accidents, the choice of therapeutic strategy depends mainly on the evaluation of life-threatening radiation-induced damage to physiological systems (9, 33) . We used three new biological indicators to assess these damages: the FL concentration for the hematopoietic system (11), citrulline for the digestive tract (12) , and plasma oxysterols for lipid metabolism (17) . The initial FL assay showed a very high concentration, strongly suggestive of severe bone marrow aplasia (14) . As in most radiation casualties, however, the irradiation was heterogeneous, and some residual hematopoiesis persisted. This was suggested by the percentage of WBC without chromosome aberrations, the presence of circulating lymphocytes 19 days after irradiation, the circulating CD34 ϩ cells, and the stabilization of the FL concentration during the first week of followup. Moreover, as soon as cytokine injections began, the FL concentration decreased. This indicated endogenous hematopoietic recovery, which was confirmed by the recovery of the blood cell populations and by the increase in the number of progenitors and circulating CD34 ϩ cells during the following week. Eighteen months after irradiation, the patient, who is still being followed by the medical team in charge of his treatment, is alive and well (T. de Revel and T. Fagot, personal communication). Overall, these results confirm the interest in using FL to assess hematopoietic activity in radiation accident victims, as previous studies have suggested (10, 11, 34) .
Monitoring plasma oxysterols as physiological indicators has recently been proposed to assess functional or structural damage in various diseases of the liver (35), the cardiovascular system (30) , or the neurological system (such as Alzheimer disease) (29) . Our results demonstrate for the first time that plasma oxysterol concentrations are modified after irradiation in humans. These modifications may indicate the presence of functional damage to the liver and cardiovascular system. Functional liver damage, although without any clinical symptoms, was confirmed by the decreases in ALT and AST concentrations. Interestingly, the modification of the 7␣-OH-Chol concentration preceded that of the AST and ALT concentrations as well as of the plasma concentrations of HDL, LDL and ApoA1 and B. The high 27-OH-Chol concentration suggested radiation damage to the cardiovascular system. This was confirmed by an elevated concentration of CK-MB, a biochemical marker of cardiac disease (36) . Thus these results, although they require experimental confirmation in animal models or in clinical studies, suggest that modifications in oxysterol concentrations may predict liver or cardiovascular system damage after irradiation.
Overall, this radiation accident has several unique features. One is that the radiation dose received by the victim, dicators, however, identified some changes in organ and physiological functioning earlier than shown by the standard biochemical markers. Specifically, this was the case for the liver and the cardiovascular system. Such mixed pathology was observed previously in the Tokai-mura (31) and Nesvizh (32) accidents and was termed multiple organ dysfunction syndrome (MODS) (37) . Thus, although we observed no clinical signs of either liver or cardiovascular disease, our results suggest that the patient suffered a less severe form of radiation-induced MODS (37) , with the involvement of the hematopoietic system, the liver and the cardiovascular system. Consequently, we propose that an underlying radiation-induced MODS should be evaluated and treated in radiation accidents, regardless of the radiation dose received by the victim. This presupposes the use of specific scores including the METREPOL score designed for radiation accident victims (9) and scores for MODS that may include assessment of cardiovascular, renal, hepatic and pulmonary functions (38, 39) . It should also include the new biological indicators such as FL, citrulline and oxysterol concentrations described here. As a whole, our results confirm that the multiparameter approach for evaluation of radiation damage, including the use of these new biological indicators, together with assessment of the radiation dose and its heterogeneity, is essential for the treatment of radiation accident victims.
